Metastatic Breast Cancer Conference

Susan G. Komen® Louisiana Holds Metastatic Breast Cancer Conference
Komen Takes the Lead on Supporting Those Living With Stage IV Breast Cancer

May 8, 2019 – Baton Rouge, LA – Komen Louisiana will hold its inaugural Metastatic Breast Cancer (MBC) Conference on Saturday, June 8, 2019 at Pennington Biomedical Research Center Conference Center in Baton Rouge. The event is from 8 a.m. to 5 p.m. and is free and open to those living with metastatic breast cancer and their family and friend caregivers.

The daylong event provides discussions on emerging research, treatment options, and quality of life issues with nationally respected experts. Breakout sessions will focus on breast cancer by sub-type and metastatic location.  Additional highlighted information will include details on clinical trials, nutrition, legal matters, financial toxicity, Komen public policy initiatives surrounding MBC, and other matters of interest.

Komen Scholar, Ian Krop, MD, Ph.D., is a clinical translational medical oncologist whose primary research focuses on understanding and overcoming mechanisms of resistance to HER2-directed therapies. Dr. Krop will share about his role and the development of new therapy for HER2-positive breast cancers, including metastatic breast cancer. Dr. Krop is currently leading several clinical trials exploring combinations of novel targeted therapies designed to overcome resistance to HER2-directed agents

The event will be live-streamed on the Komen Louisiana Facebook page to ensure the accessibility of information for those who are unable to attend. Registration is open to Louisiana residents and others living with MBC at komenlouisiana.org/mbc.

For more information about the Komen Louisiana Metastatic Breast Conference, contact us at info@komenlouisiana.org or by calling 225-615-8740.

About Susan G. Komen® and Komen Louisiana

Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Komen was founded in 1982 by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life. Komen Louisiana is working to better the lives of those facing breast cancer in the local community. Komen Louisiana has invested over $15,000,000 in community breast health programs in its 56-parish service area and has helped contribute to the more than $988 million invested globally in research. For more information, call 225-615-8740 or visit www.komenlouisiana.org.

Connect with Komen Louisiana on Facebook at facebook.com/KomenLouisiana, Twitter at KomenLouisiana, and Instagram at komenlouisiana

Komen Louisiana Press Release